Hält derzeit Positionen bei Adaptimmune Therapeutics PLC, Medimmune LLC and Ardelyx Inc
Position | Company | Period |
---|---|---|
Chief Operating Officer | Adaptimmune Therapeutics PLC | 15. März 2017 - |
Executive Vice President, General Counsel | Medimmune LLC | None - |
Independent Director | Ardelyx Inc | 26. Oktober 2015 - |
Executive Vice President, General Counsel | Infinity Pharmaceuticals Inc | 19. Oktober 2015 - 2. September 2016 |
Acting Chief Operating Officer | Salix Pharmaceuticals Ltd | 30. Januar 2015 - 1. April 2015 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
13.599
-40.2%
0,679.152 USD |
13.599 -40.2% | 0,67 | 9.152 USD | |
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.309
-40.5%
0,673.573 USD |
5.309 -40.5% | 0,67 | 3.573 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
5.220
-39.9%
0,854.458 USD |
5.220 -39.9% | 0,85 | 4.458 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.009
-39.6%
0,843.354 USD |
4.009 -39.6% | 0,84 | 3.354 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.440
-37.9%
1,868.250 USD |
4.440 -37.9% | 1,86 | 8.250 USD | |
2023-01-12 | 2023-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.973
-38.0%
1,718.484 USD |
4.973 -38.0% | 1,71 | 8.484 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.584
-38.3%
1,696.071 USD |
3.584 -38.3% | 1,69 | 6.071 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
4.368
-37.3%
3,1913.942 USD |
4.368 -37.3% | 3,19 | 13.942 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.248
-37.5%
3,547.967 USD |
2.248 -37.5% | 3,54 | 7.967 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.770
-37.3%
3,5613.409 USD |
3.770 -37.3% | 3,56 | 13.409 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.490
-37.3%
4,0614.184 USD |
3.490 -37.3% | 4,06 | 14.184 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.234
-37.2%
6,1513.744 USD |
2.234 -37.2% | 6,15 | 13.744 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.499
-37.4%
5,3318.642 USD |
3.499 -37.4% | 5,33 | 18.642 USD | |
2020-12-15 | 2020-12-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
K Kauf |
207.000
+266.0%
0,69143.824 USD |
207.000 +266.0% | 0,69 | 143.824 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.397
-39.9%
5,1312.308 USD |
2.397 -39.9% | 5,13 | 12.308 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
3.731
-39.8%
1,204.477 USD |
3.731 -39.8% | 1,20 | 4.477 USD | |
2019-01-16 | 2019-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Verkauf |
2.271
-37.8%
5,3712.194 USD |
2.271 -37.8% | 5,37 | 12.194 USD |